Neue Aspekte HPV-positiver Kopf-Hals-Karzinome. Highlights vom ASCO-Kongress 2011

B Kofler; F C Uecker; A Muenscher; R Knecht

doi:10.1007/s00106-011-2465-y

Neue Aspekte HPV-positiver Kopf-Hals-Karzinome. Highlights vom ASCO-Kongress 2011

Standard

Neue Aspekte HPV-positiver Kopf-Hals-Karzinome. Highlights vom ASCO-Kongress 2011. / Kofler, B; Uecker, F C; Muenscher, A; Knecht, R.

In: HNO, Vol. 60, No. 5, 05.2012, p. 404-7.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Kofler, B, Uecker, FC, Muenscher, A & Knecht, R 2012, 'Neue Aspekte HPV-positiver Kopf-Hals-Karzinome. Highlights vom ASCO-Kongress 2011', HNO, vol. 60, no. 5, pp. 404-7. https://doi.org/10.1007/s00106-011-2465-y

APA

Kofler, B., Uecker, F. C., Muenscher, A., & Knecht, R. (2012). Neue Aspekte HPV-positiver Kopf-Hals-Karzinome. Highlights vom ASCO-Kongress 2011. HNO, 60(5), 404-7. https://doi.org/10.1007/s00106-011-2465-y

Vancouver

Kofler B, Uecker FC, Muenscher A, Knecht R. Neue Aspekte HPV-positiver Kopf-Hals-Karzinome. Highlights vom ASCO-Kongress 2011. HNO. 2012 May;60(5):404-7. https://doi.org/10.1007/s00106-011-2465-y

Bibtex

@article{0b0c6f8725c04a04aef7277ab63adaa0,

title = "Neue Aspekte HPV-positiver Kopf-Hals-Karzinome. Highlights vom ASCO-Kongress 2011",

abstract = "HPV-positive head and neck carcinoma is significantly different than tobacco- and alcohol-induced cancer. Between 30% and 50% of oropharyngeal cancers are associated with human papillomavirus (HPV). Studies still show an increasing incidence. HPV-positive head and neck cancer patients have a better prognosis due to a better response to therapy. Especially patients with gene overexpression of immunological proteins in the antigen presentation are suggested to benefit from radiotherapy. A current retrospective study shows better outcomes for patients treated with radiotherapy in combination with biological targets compared to radiochemotherapy.",

keywords = "Chemoradiotherapy, Evidence-Based Medicine, Head and Neck Neoplasms, Humans, Molecular Targeted Therapy, Papillomaviridae",

author = "B Kofler and Uecker, {F C} and A Muenscher and R Knecht",

year = "2012",

month = may,

doi = "10.1007/s00106-011-2465-y",

language = "Deutsch",

volume = "60",

pages = "404--7",

journal = "HNO",

issn = "0017-6192",

publisher = "Springer",

number = "5",

}

RIS

TY - JOUR

T1 - Neue Aspekte HPV-positiver Kopf-Hals-Karzinome. Highlights vom ASCO-Kongress 2011

AU - Kofler, B

AU - Uecker, F C

AU - Muenscher, A

AU - Knecht, R

PY - 2012/5

Y1 - 2012/5

N2 - HPV-positive head and neck carcinoma is significantly different than tobacco- and alcohol-induced cancer. Between 30% and 50% of oropharyngeal cancers are associated with human papillomavirus (HPV). Studies still show an increasing incidence. HPV-positive head and neck cancer patients have a better prognosis due to a better response to therapy. Especially patients with gene overexpression of immunological proteins in the antigen presentation are suggested to benefit from radiotherapy. A current retrospective study shows better outcomes for patients treated with radiotherapy in combination with biological targets compared to radiochemotherapy.

AB - HPV-positive head and neck carcinoma is significantly different than tobacco- and alcohol-induced cancer. Between 30% and 50% of oropharyngeal cancers are associated with human papillomavirus (HPV). Studies still show an increasing incidence. HPV-positive head and neck cancer patients have a better prognosis due to a better response to therapy. Especially patients with gene overexpression of immunological proteins in the antigen presentation are suggested to benefit from radiotherapy. A current retrospective study shows better outcomes for patients treated with radiotherapy in combination with biological targets compared to radiochemotherapy.

KW - Chemoradiotherapy

KW - Evidence-Based Medicine

KW - Head and Neck Neoplasms

KW - Humans

KW - Molecular Targeted Therapy

KW - Papillomaviridae

U2 - 10.1007/s00106-011-2465-y

DO - 10.1007/s00106-011-2465-y

M3 - SCORING: Zeitschriftenaufsatz

C2 - 22570004

VL - 60

SP - 404

EP - 407

JO - HNO

JF - HNO

SN - 0017-6192

IS - 5

ER -